002022 Shanghai Kehua Bio-engineering
- 7.52
- +0.16+2.17%
Shanghai Kehua Bio-engineering News
Kehua Biotech: An indicative announcement on the “Kehua Convertible Bonds” expected to trigger a downward revision of the conversion price
* ST Kehua: progress announcement after the disclosure of the major asset restructuring plan
* ST Kehua: progress announcement after the disclosure of the major asset restructuring plan
* ST Kehua: progress announcement after the disclosure of the major asset restructuring plan
*ST Kehua: An indicative announcement on the conditions that Kehua convertible bonds are expected to trigger a downward correction in the conversion price
* ST Kehua: progress announcement after the disclosure of the major asset restructuring plan
* ST Kehua: announcement on the interest payment of Convertible Bonds in 2022
* ST Kehua: announcement on the implementation of Annual Distribution of Rights and interests in 2021
* ST Kehua: Shanghai Kehua Biological Engineering Co., Ltd. publicly issued convertible bonds 2022 follow-up rating report
Kehua Biotech: 2021 Interest Payment Announcement on Convertible Corporate Bonds
Kehua Biotech: Online Roadshow Announcement on Public Issuance of Convertible Corporate Bonds
Kehua Biotech: 2020 Convertible Corporate Bonds Credit Rating Report
Kehua Biotech: Announcement on Adjusting the Plan for the Public Issuance of Convertible Corporate Bonds
Kehua Biotech: Announcement on the impact of diluted spot returns from the public issuance of convertible corporate bonds on the company's main financial indicators and the filling measures taken by the company (revised draft)
Kehua Biotech: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds (Revised Draft)
Kehua Biology: announcement on the reply to the letter of preparation for the meeting of the Review Committee for the Public issuance of Convertible Bonds
Kehua Biotech: Announcement on First Feedback Response and Revision of Application Documents for the Public Issuance of Convertible Corporate Bonds
Kehua Biotech: Feedback from the Company and CITIC Securities Co., Ltd. on the application documents for the public issuance of convertible corporate bonds
Kehua Biotech: Announcement on the acceptance of the application for the public issuance of convertible corporate bonds by the China Securities Regulatory Commission
Kehua Biotech: Announcement on the impact of diluted spot returns from the public issuance of convertible corporate bonds on the company's main financial indicators and the compensation measures taken by the company
Analysis
Price Target
No Data
